Pep AI: Peptide GLP-1 Tracker from Zode Development LLC helps patients manage injectable peptide regimens and monitor treatment progress. The app centralizes dose records, schedules reminders, and charts weight to make adherence visible over time. It targets people on GLP-1 medications and peptide therapy who need a focused tracking tool rather than a generic health diary. It requires iOS 16.0 or later.

How the app supports injection-site management

The app includes a visual tool to log and rotate injection sites, a feature designed to reduce local tissue irritation during long-term injectable therapy. Daily use translates into a simple record of the last site and a visual history that helps users avoid repeated placement. Users report the rotation view is one of the most useful parts of the interface for routine self-care.

What the AI chat and syncing behavior deliver

An integrated AI assistant answers general questions about peptide protocols and health tracking, giving quick context for routine questions. The app also typically uses standard iOS cloud features for data management, and the interface exposes basic sync options in settings. Practical note: the chat is positioned as an informational aid rather than a clinical decision tool.

Who the app fits and how it sits in the iPhone ecosystem

The app is aimed squarely at patients on GLP-1 medications and people using peptide therapies who prefer a specialised tracker. The developer focuses on health-oriented iOS utilities, and user reception highlights the app's narrow focus and clean presentation. Because it runs only on iPhone, users who want cross-platform continuity should consider that limitation before adopting it as a primary regimen record.

A focused option for peptide and GLP-1 users, with a clear scope

The app is a practical, niche option for patients who want dedicated oversight of injectable regimens and progress; its specialization makes it less suitable as a general health tracker. The targeted design benefits routine injectable therapy management, though users who need multi-device continuity should note the iPhone-centric approach. For those on GLP-1 or peptide protocols, the app suits steady, single-device tracking workflows.